Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of Semnur Pharmaceuticals, Inc. (f/k/a Denali Capital Acquisition Corp.) of our report dated April 21, 2025, except for the effects of the reverse recapitalization described in Note 1 to the financial statements, as to which the date is September 22, 2025, relating to the financial statements of Semnur, Inc. (Legacy Semnur Pharmaceuticals, Inc.), which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

Pipara & Co LLP

/s/ Pipara & Co LLP

Delhi, India

December 19, 2025

 

 

 

New York Office: 1270, Ave of Americas, Rockefeller Center, FL7, New York – 10020, USA +1 (646) 387 - 2034		Corporate Office: “Pipara Corporate House” Near Bandhan Bank Ltd., Netaji Marg, Law Garden, Ahmedabad - 380006		Dubai Office: 1011, B-Block, Mazaya Centre, Sheikh Zayed Rd - Al Wasl - Dubai - UAE		Mumbai Office: #3, 13th floor, Tradelink, ‘E’ Wing, A - Block, Kamala Mills, Senapati Bapat Marg, Lower Parel, Mumbai - 400013		Delhi Office: Green Park Desq Work, Gate No. 1, 49/1 Yusuf Sarai, Nr. Green Park Metro Station, Delhi - 110016		Hyderabad Office: 509, Sandhya Techno - 1, Opp. KIMS Hospital, Raidurgam, Hyderabad Telangana, India, 500036
naman@pipara.com		T: + 91 79 40 370370		info@pipara.com		E: pipara@pipara.com		chintan.jain@pipara.com		sharyansh.ranka@pipara.com